UHC – Medicare Advantage Reimbursement Policy Update Bulletin
August 5, 2022Molecular Pathology Policy Professional and Facility – 10/01/2022
The policy has been updated to provide further details of payment policies associated with molecular pathology claims: • Reimbursement Guidelines section revised to include guidelines for Multiple Gene Testing with code table references for Tier 1 and Tier 2 Molecular Pathology codes, Genomic Sequencing Procedures and Other Molecular Multianalyte Assays.
• Definitions section revised to include definitions for Genomic Sequencing Procedures and Other Molecular Multianalyte Assays and Proprietary Laboratory Analysis (PLA) Codes.
• Questions and Answers (Q&A) section updated to include additional Q&A specific to Multiple Gene Testing